Literature DB >> 15782130

BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase.

Anis Feki1, Charles Edward Jefford, Philip Berardi, Jian-Yu Wu, Laetitia Cartier, Karl-Heinz Krause, Irmgard Irminger-Finger.   

Abstract

The BRCA1-associated RING domain protein BARD1 acts with BRCA1 in double-strand break repair and ubiquitination. BARD1 plays a role as mediator of apoptosis by binding to and stabilizing p53, and BARD1-repressed cells are resistant to apoptosis. We therefore investigated the mechanism by which BARD1 induces p53 stability and apoptosis. The apoptotic activity of p53 is regulated by phosphorylation. We demonstrate that BARD1 binds to unphosphorylated and serine-15 phosphorylated forms of p53 in several cell types and that the region required for binding comprises the region sufficient for apoptosis induction. In addition, BARD1 binds to Ku-70, the regulatory subunit of DNA-PK, suggesting that the mechanism of p53-induced apoptosis requires BARD1 for the phosphorylation of p53. Upregulation of BARD1 alone is sufficient for stabilization of p53 and phosphorylation on serine-15, as shown in nonmalignant epithelial cells and ovarian cancer cells, NuTu-19, which are defective in apoptosis induction and express aberrant splice variants of BARD1. Stabilization and phosphorylation of p53 in NuTu-19 cells, as well as apoptosis, can be induced by the exogenous expression of wild-type BARD1, suggesting that BARD1, by binding to the kinase and its substrate, catalyses p53 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15782130     DOI: 10.1038/sj.onc.1208491

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  36 in total

Review 1.  The Ku complex: recent advances and emerging roles outside of non-homologous end-joining.

Authors:  Sanna Abbasi; Gursimran Parmar; Rachel D Kelly; Nileeka Balasuriya; Caroline Schild-Poulter
Journal:  Cell Mol Life Sci       Date:  2021-04-15       Impact factor: 9.261

2.  Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies.

Authors:  S-M Karppinen; R B Barkardottir; K Backenhorn; T Sydenham; K Syrjäkoski; J Schleutker; T Ikonen; K Pylkäs; K Rapakko; H Erkko; G Johannesdottir; A-M Gerdes; M Thomassen; B A Agnarsson; M Grip; A Kallioniemi; J Kere; L A Aaltonen; A Arason; P Møller; T A Kruse; A Borg; R Winqvist
Journal:  J Med Genet       Date:  2006-07-06       Impact factor: 6.318

3.  Integrin α5 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells.

Authors:  Sicong Hou; Weiguo Jin; Weiming Xiao; Bin Deng; Dacheng Wu; Jiehua Zhi; Keyan Wu; Xiaowei Cao; Shuai Chen; Yanbing Ding; Hongcan Shi
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

Review 4.  Novel RING E3 ubiquitin ligases in breast cancer.

Authors:  Angelika Burger; Yutaka Amemiya; Richard Kitching; Arun K Seth
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

5.  BARD1 expression predicts outcome in colon cancer.

Authors:  Judith C Sporn; Torsten Hothorn; Barbara Jung
Journal:  Clin Cancer Res       Date:  2011-06-21       Impact factor: 12.531

6.  Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers.

Authors:  Julian C Y Ip; Tony C Y Pang; Anthony R Glover; Patsy Soon; Jing Ting Zhao; Stephen Clarke; Bruce G Robinson; Anthony J Gill; Stan B Sidhu
Journal:  Oncologist       Date:  2015-02-05

7.  Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.

Authors:  Kristopher R Bosse; Sharon J Diskin; Kristina A Cole; Andrew C Wood; Robert W Schnepp; Geoffrey Norris; Le B Nguyen; Jayanti Jagannathan; Michael Laquaglia; Cynthia Winter; Maura Diamond; Cuiping Hou; Edward F Attiyeh; Yael P Mosse; Vanessa Pineros; Eva Dizin; Yongqiang Zhang; Shahab Asgharzadeh; Robert C Seeger; Mario Capasso; Bruce R Pawel; Marcella Devoto; Hakon Hakonarson; Eric F Rappaport; Irmgard Irminger-Finger; John M Maris
Journal:  Cancer Res       Date:  2012-02-20       Impact factor: 12.701

8.  PI 3 kinase related kinases-independent proteolysis of BRCA1 regulates Rad51 recruitment during genotoxic stress in human cells.

Authors:  Ian Hammond-Martel; Helen Pak; Helen Yu; Raphael Rouget; Andrew A Horwitz; Jeffrey D Parvin; Elliot A Drobetsky; El Bachir Affar
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

9.  Transcription-coupled DNA double-strand breaks are mediated via the nucleotide excision repair and the Mre11-Rad50-Nbs1 complex.

Authors:  Josée Guirouilh-Barbat; Christophe Redon; Yves Pommier
Journal:  Mol Biol Cell       Date:  2008-07-16       Impact factor: 4.138

10.  Small-molecule probe reveals a kinase cascade that links stress signaling to TCF/LEF and Wnt responsiveness.

Authors:  Jiongjia Cheng; Masanao Tsuda; Karl Okolotowicz; Mary Dwyer; Paul J Bushway; Alexandre R Colas; Joseph J Lancman; Dennis Schade; Isaac Perea-Gil; Arne A N Bruyneel; Jaechol Lee; Nirmal Vadgama; Justine Quach; Wesley L McKeithan; Travis L Biechele; Joseph C Wu; Randall T Moon; P Duc Si Dong; Ioannis Karakikes; John R Cashman; Mark Mercola
Journal:  Cell Chem Biol       Date:  2021-01-26       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.